Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Pending delisting stigma

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on May 05, 2023 6:37pm

96 Views

Post# 35434044

RE:RE:Pending delisting stigma

Scarlet, It's to late the celebrating has begun, Happy Cinco de Mayo to all and cheers to a positive AGM next week!

scarlet1967 wrote: Hey Leo,
I don't want to spoil your celebration but the bid price has to be above $1. Hopefully as better sales' momentum continues and more clarity about the oncology program followed by a balanced marketing takes the valuation much higher than $1.
Lee430 wrote: Yay closed above $1.00 today!...Only 9 more days of this to remove the NAZ delisting guillotine hanging over us. It's a small win today but a good enough excuse for me to celebrate tonight.